{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:03:03Z","timestamp":1788184983406,"version":"build-2803163510"},"reference-count":41,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T00:00:00Z","timestamp":1371081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>In patients with head and neck and esophageal tumors, nutritional status may deteriorate during concurrent chemoradiotherapy (CRT). The aim of this study was to investigate the influence of enteral nutrition enriched with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on body composition and nutritional and functional status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      In a controlled, randomized, prospective, double\u2010blind, multicenter study, 111 patients with head and neck and esophageal cancer undergoing concurrent CRT received either an enteral standard nutrition (control group) or disease\u2010specific enteral nutrition Supportan\n                      <jats:sup>\u00ae<\/jats:sup>\n                      \u2010containing EPA+DHA (experimental group) via percutaneous endoscopic gastrostomy. The primary endpoint was the change of body cell mass (BCM) following CRT at weeks 7 and 14 compared with the baseline value. Secondary endpoints were additional parameters of body composition, anthropometric parameters, and nutritional and functional status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The primary endpoint of the study, improvement in BCM, reached borderline statistical significance. Following CRT, patients with experimental nutrition lost only 0.82 \u00b1 0.64 kg of BCM compared with 2.82 \u00b1 0.77 kg in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.055). The objectively measured nutritional parameters, such as body weight and fat\u2010free mass, showed a tendency toward improvement, but the differences were not significant. The subjective parameters, in particular the Kondrup score (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.0165) and the subjective global assessment score (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.0065) after follow\u2010up improved significantly in the experimental group, compared with the control group. Both enteral regimens were safe and well tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      Enteral nutrition with EPA and DHA may be advantageous in patients with head and neck or esophageal cancer by improving parameters of nutritional and functional status during CRT.\n                      <jats:bold>\n                        <jats:italic>Cancer<\/jats:italic>\n                        2013;119:3343\u201353\n                      <\/jats:bold>\n                      . \u00a9\n                      <jats:italic>2013 American Cancer Society<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.28197","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T12:18:33Z","timestamp":1371125913000},"page":"3343-3353","source":"Crossref","is-referenced-by-count":69,"title":["A disease\u2010specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: Results of a randomized, controlled, multicenter trial"],"prefix":"10.1002","volume":"119","author":[{"given":"Rainer","family":"Fietkau","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Erlangen University Hospital Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lewitzki","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy University Hospital Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuhnt","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy University Hospital Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"H\u00f6lscher","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiooncology University Hospital Carl Gustav Carus Dresden Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens\u2010F.","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiooncology Medical Department Georg\u2010August University G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Radiooncology University Hospital T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wiegel","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiooncology University Hospital Ulm Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology University Hospital, Goethe University Frankfurt\/Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Niewald","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiooncology Saarland University Medical Center Homburg\/Saar Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Hermann","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiooncology Medical Department Georg\u2010August University G\u00f6ttingen Germany"},{"name":"Centre for Radiotherapy and Radiooncology Westerstede Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Lubgan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Erlangen University Hospital Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-012-0194-0"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2006.01.020"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1079\/PNS19980083"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/014860719001400517"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70170-4"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(96)00313-9"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.11.003"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.11.071"},{"key":"e_1_2_8_10_1","first-page":"2119","article-title":"Nutritional parameters for patients with head and neck cancer","volume":"32","author":"Buntzel J","year":"2012","journal-title":"Anticancer Res."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-36939"},{"key":"e_1_2_8_12_1","first-page":"47","article-title":"Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy","volume":"174","author":"Fietkau R","year":"1998","journal-title":"Strahlenther Onkol."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(97)00030-0"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1054\/clnu.2001.0417"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00366049"},{"key":"e_1_2_8_16_1","first-page":"52","article-title":"Options for artificial nutrition of cancer patients","volume":"174","author":"Pille S","year":"1998","journal-title":"Strahlenther Onkol."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.12.3427S"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2011.214"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.110.121202"},{"key":"e_1_2_8_20_1","unstructured":"Declaration of Helsinki\u2014Ethical Principles for Medical Research Involving Human Subjects Adopted by the 18th WMA General Assembly Helsinki Finland June 1964 and amended by the 59th WMA General Assembly Seoul Korea October2008"},{"key":"e_1_2_8_21_1","unstructured":"ICH Topic E3 Note for Guidance on Structure and Content of Clinical Study Reports (CPMP\/ICH\/137\/95) 1996."},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajcn\/49.1.33","article-title":"Changes in fat\u2010free mass during weight loss measured by bioelectrical impedance and by densitometry","volume":"49","author":"Deurenberg P","year":"1989","journal-title":"Am J Clin Nutr."},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.06.004"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1152\/jappl.1990.68.5.2246","article-title":"Sensitivity of bioelectrical impedance to detect changes in human body composition","volume":"68","author":"Pennock BE","year":"1990","journal-title":"J Appl Physiol."},{"key":"e_1_2_8_25_1","first-page":"589","article-title":"Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non\u2010ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices","volume":"22","author":"Kawaguchi T","year":"2008","journal-title":"Int J Mol Med."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.20524"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0261-5614(02)00214-5"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.08.007"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00049-X"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026442201191"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2466\/pms.2001.93.2.323"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533441"},{"key":"e_1_2_8_33_1","unstructured":"European Agency for the Evaluation of Medicinal Products (EMEA).CH Topic E9 Statistical Principles for Clinical Trials. Step 4 Consensus guideline. CPMP\/ICH\/363\/96. 1998.1999."},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1017\/S000711450765795X"},{"key":"e_1_2_8_35_1","article-title":"Eicosapentaenoic acid (EPA, an omega\u20103 fatty acid from fish oils) for the treatment of cancer cachexia","volume":"004597","author":"Dewey A","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.06.005"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311418709"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25709"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.124"},{"key":"e_1_2_8_40_1","first-page":"165","article-title":"Nutritional risks and colorectal cancer in a Portuguese population","volume":"20","author":"Ravasco P","year":"2005","journal-title":"Nutr Hosp."},{"key":"e_1_2_8_41_1","first-page":"1706","article-title":"Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer","volume":"44","author":"Russell DM","year":"1984","journal-title":"Cancer Res."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914NC3602_6"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.28197","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.28197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T22:00:54Z","timestamp":1760306454000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.28197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,13]]},"references-count":41,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1002\/cncr.28197"],"URL":"https:\/\/doi.org\/10.1002\/cncr.28197","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718026279.793482141","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718026279.793481041","asserted-by":"object"}]},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,13]]}}}